SCAI 2026 The End of Watchful Waiting: Long Term TAVR Evidence and a New Proactive Paradigm-Discussion 2

Video Transcription

Video Summary

The discussion focused on expanding TAVR to earlier, asymptomatic patients and the implications for workflow, resources, and quality. Speakers debated inpatient TAVR burdens, potential access benefits of treating patients sooner, and whether all valves and all programs should adopt this strategy. They emphasized that local heart teams should have flexibility, but quality standards must remain strict. The reopening of Medicare’s national coverage determination was highlighted as a chance to reconsider outdated requirements. Overall, the group agreed that innovation should be driven by physician-led quality oversight, careful patient selection, and program accountability.

Asset Caption

closed captions are computer-generated

Keywords

TAVR

aortic

TAVI

asymptomatic patients

Medicare coverage determination

heart team flexibility

quality oversight